Abbott Laboratories (ABT) has been in a clear downtrend over the past month and quarter, with shares declining more than 7% in the last 30 days and nearly 20% year-to-date. The stock recently hit near its 52-week low around 101, reflecting sustained bearish momentum. Price action shows consistent lower highs and lows, with the current price hovering around 103 well below longer-term averages. This structure confirms sellers' control, though historical long-term support near current levels has held declines in the past.
Traders are eyeing immediate support at 101-102, aligning with recent lows, accumulated volume zones, and pivot S1 levels near 101.80. A break below could target deeper supports around 100.22 (S3 pivot). Resistance begins at the pivot point of 102.79, followed by R1 at 103.38 and R2 at 104.37. Stronger overhead resistance sits at the 20-day moving average near 106 and 50-day at 109, where prior consolidation occurred. These levels represent key zones where price has reversed multiple times recently.
All major moving averages signal bearish alignment for ABT. The 50-day simple moving average stands at 109.25, while the 200-day is at 123.99, with price trading significantly below both. Shorter-term EMAs, such as the 20-day at 106 and 10-day at 104, further reinforce downward pressure. This configuration, including a persistent 'death cross' where shorter MAs remain under longer ones, underscores the lack of bullish reversal momentum.
The Relative Strength Index (RSI) for ABT reads around 32-34 on a 14-period basis, placing it in neutral to oversold territory and suggesting potential exhaustion among sellers. Stochastic %K (14) is near 14-25, approaching oversold levels that could prompt a bounce. MACD (12,26) hovers at -2.6, with mixed interpretations—some noting the line above signal for subtle bullish divergence, though overall histogram remains negative. These indicators point to weakening downside momentum amid the downtrend.
Trading volume for ABT has been mixed, with recent sessions showing below-average participation during declines, creating some divergence that warrants caution. Average daily volume exceeds 11 million shares, but spikes have accompanied key breakdowns, confirming institutional selling. Elevated historic volatility around 17-20% over shorter periods highlights choppy trading ranges near current supports.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns for ABT. These signals identify potential buy or sell opportunities by recognizing trends, momentum shifts, and recurring chart formations that have proven reliable over time. Traders rely on them to pinpoint entry and exit points, validate ongoing trends, and refine decision-making processes without emotional bias. By processing real-time and historical inputs, the AI provides objective insights tailored for both short-term trades and longer holds. Explore the AI Daily Buy/Sell Signals to integrate advanced pattern recognition into your ABT analysis.
Traders will monitor ABT for a potential bounce from supports near 101-102, especially if RSI dips further into oversold and stochastics generate crossovers. A close above 104-105 could challenge the 20-day MA at 106, signaling short-term relief. Conversely, failure at support risks testing 100, while sustained weakness keeps bearish bias intact. Watch moving average interactions, MACD histogram shifts, and volume for confirmation of direction. Oversold readings suggest caution on further downside aggression.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, ABT has been loosely correlated with SYK. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then SYK could also see price increases.
| Ticker / NAME | Correlation To ABT | 1D Price Change % |
|---|---|---|
| ABT | 100% | -0.81% |
| Health Services category (403 stocks) | 16% Poorly correlated | +2.29% |
| Medical/Nursing Services category (214 stocks) | 13% Poorly correlated | -0.72% |